Such a model would be inclusive of patients with mutations in major ALS genes [8,15,17,57,71,72,73], even if for such genes as C9orf72, SOD1, TARDBP and FUS a reduced number of pathogenetic steps has been recently suggested [74]. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.